Global Sulfadimidine Market Size To Worth USD 1.94 Billion By 2033 | CAGR of 5.46%
Category: HealthcareGlobal Sulfadimidine Market Size To Worth USD 1.94 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Sulfadimidine Market Size is Expected to Grow from USD 1.14 Billion in 2023 to USD 1.94 Billion By 2033, at a CAGR of 5.46% during the Forecast Period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 270 pages with 135 Market data tables and figures & charts from the report on the "Global Sulfadimidine Market Size, Share, and COVID-19 Impact Analysis, By Formulation Type (Injection, Tablet, Suspension, and Powder), By Application (Human Medicine and Veterinary Medicine), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Veterinary Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/sulfadimidine-market
The sulfadimidine market involves the development, production, and distribution of sulfadimidine used in veterinary medicine and animal health management. Sulfadimidine is a common antibiotic used in veterinary medicine to maintain pig weight gain, promote growth, and improve feed efficiency. It works well against various illnesses affecting animals producing food, such as acute mastitis, acute metritis, colibacillosis, calf diphtheria, necrotic pododermatitis, bovine respiratory disease complex, and coccidiosis. Adults are advised to consume 0.5-1 g of sulfadimidine three or four times a day. Advancements in sulfadimidine formulations have led to market growth. Government initiatives, such as the National Animal Disease Control Programme (NADCP) and Livestock Health and Disease Control Programme (LHDCP) in India, drive market growth. The NADCP aims to eradicate brucellosis and foot and mouth disease (FMD) in pigs, cattle, buffalo, sheep, and goats by 2030 and control it through vaccination by 2025. The LHDCP also aims to lower the dangers to animal health, including vaccination against classic swine fever, brucellosis, Peste des Petits ruminants, and foot and mouth disease. However, stringent regulatory guidelines limit the market expansion.
The powder segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the formulation type, the global sulfadimidine market is categorized as injection, tablet, suspension, and powder. Among these, the powder segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. The growth of the segment is attributed to its faster absorption, convenience for geriatric and pediatric populations, minimal risk of contamination, enhanced solubility, ease of administration, and flexibility in dosing.
The veterinary medicine segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global sulfadimidine market is categorized as the global sulfadimidine market is categorized into human medicine and veterinary medicine. Among these, the veterinary medicine segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is owing to its effective against bacterial infections in livestock and poultry, treating respiratory and gastrointestinal issues, is inexpensive, suitable for large-scale farming, and often combined with drugs like trimethoprim.
The online pharmacies segment held the greatest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global sulfadimidine market is categorized into retail pharmacies, hospital pharmacies, online pharmacies, and veterinary clinics. Among these, the online pharmacies segment held the greatest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. The segment dominance is attributed to the convenience, provides privacy and confidentiality, ease of to access all types of sulfadimidine products, affordable prices, expert advice and guidance, home delivery, provision of detailed descriptions of the medications, and growing trend of online shopping.
North America is expected to hold the greatest share of the global sulfadimidine market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global Sulfadimidine market over the forecast period. The growth of the sulfadimidine market in the United States is largely driven by increased awareness and modern animal healthcare infrastructure, as well as the need for efficient therapies in human and veterinary medicine due to the increasing incidence of antibiotic-resistant illnesses.
Asia Pacific is predicted to grow at the fastest share throughout the estimated period. The Asia-Pacific sulfadimidine market is expected to grow due to increased awareness of animal health and sustainable farming practices. China and India are leading the market due to their robust manufacturing capabilities and high domestic demand. Governments are enforcing stricter regulations to combat antibiotic resistance in animals, driving steady growth in the pharmaceutical formulations sector.
Major key players in the global sulfadimidine market are Cipla Limited, Sun Pharmaceutical Industries Ltd., Abbott Laboratories, GlaxoSmithKline plc, Sanofi, Teva Pharmaceuticals, Mylan N.V., Novartis AG, Eli Lilly Company, Takeda Pharmaceutical Company Limited, Pfizer Inc., Bristol- Myers Squibb Company, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In October 2022, Huvepharma®, Inc. re-launched PoultrySulfa®, the only FDA-approved triple-sulfa veterinary product for animal health. This water-soluble antibiotic powder helps control coccidiosis and acute fowl cholera in chickens and turkeys by treating pathogens susceptible to sulfamerazine, sulfamethazine, and sulfaquinoxaline.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global sulfadimidine market based on the below-mentioned segments:
Global Sulfadimidine Market, By Formulation Type
- Injection
- Tablet
- Suspension
- Powder
Global Sulfadimidine Market, By Application
- Human Medicine
- Veterinary Medicine
Global Sulfadimidine Market, By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Veterinary Pharmacies
Global Sulfadimidine Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?